Vontobel Holding Ltd. Gilead Sciences, Inc. Transaction History

Vontobel Holding Ltd.

$29.2 Billion
Q3 2024

A detailed history of Vontobel Holding Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 259,115 shares of GILD stock, worth $23.9 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

259,115

Previous 262,502 1.29%

Holding current value

$23.9 Million

Previous $18 Million 20.59%

% of portfolio

0.07%

Previous 0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$66.59 - $83.99 $225,540 - $284,474	-3,387 Reduced 1.29%	259,115 $21.7 Million
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $2.2 Million - $2.54 Million	-34,902 Reduced 11.74%	262,502 $18 Million
Q1 2024 May 10, 2024	SELL	$71.58 - $87.29 $12.9 Million - $15.7 Million	-179,989 Reduced 37.7%	297,404 $21.8 Million
Q4 2023 Jun 03, 2024	BUY	$73.27 - $83.09 $1 Million - $1.13 Million	13,653 Added 5.51%	261,313 $21.2 Million
Q4 2023 Jan 29, 2024	BUY	$73.27 - $83.09 $2.02 Million - $2.29 Million	27,619 Added 6.14%	477,393 $38.7 Million
Q3 2023 Jun 03, 2024	BUY	$73.94 - $80.67 $1.01 Million - $1.1 Million	13,631 Added 5.82%	247,660 $18.6 Million
Q3 2023 Oct 10, 2023	BUY	$73.94 - $80.67 $2.29 Million - $2.5 Million	30,968 Added 7.39%	449,774 $33.7 Million
Q2 2023 Jun 03, 2024	BUY	$76.01 - $86.7 $5.57 Million - $6.35 Million	73,225 Added 45.54%	234,029 $18 Million
Q2 2023 Jul 24, 2023	BUY	$76.01 - $86.7 $11 Million - $12.6 Million	144,795 Added 52.84%	418,806 $32.3 Million
Q1 2023 Jun 03, 2024	SELL	$77.31 - $88.08 $10.6 Million - $12 Million	-136,600 Reduced 45.93%	160,804 $13.3 Million
Q1 2023 Apr 12, 2023	BUY	$77.31 - $88.08 $9.8 Million - $11.2 Million	126,708 Added 86.02%	274,011 $22.7 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $696,986 - $1 Million	-11,184 Reduced 7.06%	147,303 $12.6 Million
Q3 2022 Nov 04, 2022	BUY	$59.54 - $68.01 $131,166 - $149,826	2,203 Added 1.41%	158,487 $10 Million
Q2 2022 Jul 27, 2022	SELL	$57.72 - $65.01 $566,752 - $638,333	-9,819 Reduced 5.91%	156,284 $9.76 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $148,217 - $185,732	-2,559 Reduced 1.52%	166,103 $9.91 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $7.65 Million - $8.68 Million	-117,879 Reduced 41.14%	168,662 $12.4 Million
Q3 2021 Oct 29, 2021	SELL	$67.69 - $73.03 $8.61 Million - $9.29 Million	-127,184 Reduced 30.74%	286,541 $20 Million
Q2 2021 Aug 06, 2021	SELL	$63.47 - $69.35 $2.27 Million - $2.48 Million	-35,822 Reduced 7.97%	413,725 $28.1 Million
Q1 2021 May 11, 2021	SELL	$60.0 - $68.46 $4.43 Million - $5.05 Million	-73,800 Reduced 14.1%	449,547 $29.1 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $29.6 Million - $33.8 Million	523,347 New	523,347 $35.6 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Account

Vontobel Holding Ltd. Gilead Sciences, Inc. Transaction History